SAB Biotherapeutics, Inc.

Ownership Transactions Reported by 29 Insiders

Symbol
SABS, SABSW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
777 W 41 St St, Suite 401, Miami Beach, Florida

Insiders trading volume in the past year

SAB Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Andrew Moin Director $32.4M Nov 24, 2023
Sessa Capital (Master), L.P. Director $32.4M Nov 24, 2023
Edward D. Hamilton 10%+ Owner $9.35M Oct 22, 2021
Eddie Joe Sullivan PRESIDENT, Director $4.6M +$1.53K +0.03% Jul 15, 2024
Ilan Katz Director, 10%+ Owner $2.68M Oct 13, 2021
Helen K. Ellias Director $2.51M Nov 24, 2023
Samuel J. Reich CEO & EXECUTIVE CHAIRMAN, Director $675K +$9.84K +1.48% Jul 15, 2024
Alexandra Kropotova Chief Medical Officer $242K Feb 21, 2024
Michael King Chief Financial Officer $4.4K +$4.5K Feb 21, 2024
Melissa Vera Ullerich Chief Communications Officer Mar 16, 2022
Scott Giberson Director Jul 15, 2024
William James Polvino Director Jul 15, 2024
Charles Hiram Randall Chief Strategy Officer Oct 22, 2021
Carlos N. Carillo SVP Regulatory Affairs Oct 22, 2021
Christoph Bausch Chief Operating Officer Feb 21, 2024
Mervyn Turner Director Oct 22, 2021
Jerry Lynn Pommer Chief Compliance Officer Mar 16, 2022
Hua Wu SVP Research & Product Dev. Oct 22, 2021
Russell Beyer Chief Financial Officer Mar 14, 2023
Jay S. Skyler Director Jul 15, 2024
Bruce Kipp Erickson Chief Operating Officer Mar 16, 2022
Mark Conley Interim Chief Financial Officer, Vice President of Finance Jun 4, 2024
Lucy To Chief Financial Officer Aug 12, 2024
Frederick Finnegan Chief Business Officer Mar 16, 2022
David Charles Link Director Jul 15, 2024
Erick Lucera Director Jul 15, 2024
Jeffrey G. Spragens Director Jul 15, 2024
Christine E. Hamilton Director Jul 15, 2024
Thomas Charles Luke Chief Medical Officer Mar 16, 2022

Recent Insider Transactions by Companies or Individuals for SAB Biotherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.